| Ticker | KRTX |
|---|---|
| ISIN | US48576A1007 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, a...
El precio actual de Karuna Therapeutics, Inc. (KRTX) es de 329,83 , con una variación del 0,03%.
Karuna Therapeutics, Inc. opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones